Astra Zeneca’s diabetes drug, Farxiga met primary endpoints in a large clinical study, showing a significant reduction in hospitalization rates
The U.S. Food and Drug Administration is warning patients and doctors about a rare but serious infection that has been reported with a common class
When tissue is damaged, one of the body’s first inflammatory immune-system responders are macrophages, cells which are commonly thought of as
A new once-daily oral diabetes medication, semaglutide, was better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim’s,
Get a little dLife delivered to your inbox every week.